Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by langostaon Nov 10, 2017 7:49pm
144 Views
Post# 26943668

RE:RE:RE:RE:RE:PH1 Focus is Safety End Points Surpassed by far

RE:RE:RE:RE:RE:PH1 Focus is Safety End Points Surpassed by farMaybe you are right vestor. Yes, Big Pharma is globally competitive, Big Banks are globally competitive, in fact just about all multi-nationals are globally competitive. It doesn't stop any of them from actions that if not for the political power that they wield they could be cited as criminally litigable.
 There is enough unsavoury literature about Big Pharma and their ability to control the markets in their predominant fields. Their willingness to set ridiculous prices for their products until they are shamed by publicity to change. Witness the price for HIV drugs in Africa until the horrendous publicity they received caused them to pull an about face.
  There is one overriding consideration and that is profit, nothing takes a back seat to that number one item. It's not just companies like Monsanto providing antibiotics to the agricultural industry. It's Big Pharma that produces 75% of antibiotics that are consumed by farm animals, chickens, cows, turkeys, pigs,etc.Drugs are pumped into them to make them bigger, stronger, fatter faster, making them more profitable. Cheaper to use antibiotics produced by Big Pharma, rather that good animal hygiene, and Big Pharma agrees.
  The result is a food chain polluted with antibiotics and as a result so are our waterways. Again; the result as we ingest more and more antibiotics the more resistant we become, thus the emergence of superbugs.
  Now you tell me that Big Pharma gives a piece of feces, I think not..
It is said that generally we can relate as far forward as our great grandchildren, maybe you can throw another great in there, after that it all becomes a bit fuzzy. Looking too far into the future is not a Big Pharma priotity.    
Bullboard Posts